Pharma · Private company
Sanofi
Track this companyFree. Adds Sanofi to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs29From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline29
- Antithrombin concentrate (ATIIIC)Phase 3 · HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
- AzithromycinPhase 3 · Lung Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
- BelumosudilPhase 3 · Lung Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
- Clotting factor concentrates (CFC) or bypassing agents (BPA)Phase 3 · HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
- DuvakitugPhase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- FitusiranPhase 3 · HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
- FrexalimabPhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Itepekimab (SAR440340)Phase 3 · Chronic Rhinosinusitis With Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- LunsekimigPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Mometasone furoate nasal spray (MFNS)Phase 3 · Chronic Rhinosinusitis With Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- MRI contrast-enhancing agentsPhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Riliprubart Prefilled Pen (PFP)Phase 3 · Polyneuropathy, Inflammatory Demyelinating, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- AcetaminophenPhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- brivekimigPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- DiphenhydraminePhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- DuvakitugPhase 2 · HidradenitisClinicalTrials.gov · fetched Nov 12, 2026
- FrexalimabPhase 2 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- InsulinPhase 2 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Isatuximab SC-OBDSPhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- LunsekimigPhase 2 · Chronic Rhinosinusitis With Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- MontelukastPhase 2 · Plasma Cell Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
- SAR442970Phase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- SAR448851Phase 2 · Dementia, Alzheimer's TypeClinicalTrials.gov · fetched Nov 12, 2026
- rilzabrutinibPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Efanesoctocog alfaFactor VIII DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Procedure: Investigational ProceduresAsthmaClinicalTrials.gov · fetched Nov 12, 2026
- TeplizumabType 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis SuppurativaPHASE2 · RECRUITING · started Oct 19, 2026ClinicalTrials.gov NCT07812116 · fetched Nov 12, 2026
- A Study to Describe Patient REal-world FitusiRan ExpeRienceNOT_YET_RECRUITING · started Oct 7, 2026ClinicalTrials.gov NCT07895381 · fetched Nov 12, 2026
- Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal FunctionPHASE1 · RECRUITING · started Sep 22, 2026ClinicalTrials.gov NCT07853131 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseasePHASE2 · RECRUITING · started Jul 28, 2026ClinicalTrials.gov NCT07688213 · fetched Nov 12, 2026
- Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal CancerPHASE1 · RECRUITING · started May 20, 2026ClinicalTrials.gov NCT07500298 · fetched Nov 12, 2026
- A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical PracticeRECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07556159 · fetched Nov 12, 2026
- Long-Term Outcomes of Teplizumab in Routine Clinical CareRECRUITING · started Mar 19, 2026ClinicalTrials.gov NCT07360080 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or BPHASE3 · RECRUITING · started Dec 18, 2025ClinicalTrials.gov NCT07285460 · fetched Nov 12, 2026
- This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentRECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07290803 · fetched Nov 12, 2026
- A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerPHASE2 · RECRUITING · started Nov 6, 2025ClinicalTrials.gov NCT07133425 · fetched Nov 12, 2026
- Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple MyelomaPHASE2 · RECRUITING · started Oct 9, 2025ClinicalTrials.gov NCT06517017 · fetched Nov 12, 2026
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisPHASE3 · RECRUITING · started Oct 8, 2025ClinicalTrials.gov NCT07184996 · fetched Nov 12, 2026
- Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial HypertrophyPHASE4 · RECRUITING · started Sep 23, 2025ClinicalTrials.gov NCT06941870 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePHASE3 · RECRUITING · started Sep 17, 2025ClinicalTrials.gov NCT07190222 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 7, 2025ClinicalTrials.gov NCT06975722 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's DiseasePHASE2 · RECRUITING · started Jun 3, 2025ClinicalTrials.gov NCT06958536 · fetched Nov 12, 2026
- Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical StudyPHASE2 · ACTIVE_NOT_RECRUITING · started May 12, 2025ClinicalTrials.gov NCT06914908 · fetched Nov 12, 2026
- Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPPHASE3 · ENROLLING_BY_INVITATION · started Apr 1, 2025ClinicalTrials.gov NCT06859099 · fetched Nov 12, 2026
- A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 17, 2025ClinicalTrials.gov NCT06356571 · fetched Nov 12, 2026
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 12, 2025ClinicalTrials.gov NCT06834347 · fetched Nov 12, 2026
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06834360 · fetched Nov 12, 2026
- Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 27, 2023ClinicalTrials.gov NCT06141486 · fetched Nov 12, 2026
- Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 11, 2023ClinicalTrials.gov NCT06111586 · fetched Nov 12, 2026
- A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionPHASE3 · RECRUITING · started Oct 10, 2023ClinicalTrials.gov NCT06082037 · fetched Nov 12, 2026
- Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 1, 2015ClinicalTrials.gov NCT02570542 · fetched Nov 12, 2026